AET and Partners. Active collaboration for pharmaceutical innovation.
AET is an active collaborator in all fields of pharmaceutical innovation, from generic drugs through biosimilars to novel product development. Successful and profitable collaborations with companies from local distributors through to big pharma are supported by a flexible and innovative approach to licensing and partnering.
The level of both experience and innovation has lead to AET being partner of choice for many of the world’s leading pharmaceutical companies.
Advantages of partnering with AET
- Portfolio building for long term growth in global markets
- Extensive pipeline
- Consideration of local market needs: stability zone IV studies, inspected supply chains, local BE-studies
- Rapid market access with granted and available Marketing Authorisations (MAs)
- Over 2000 MAs
- Global licensing rights including CPPs for fast track registration